Gregory Russotti Receives Stock Award at Century Therapeutics Inc (IPSC) — SEC Form 4, Feb 06, 2023
SEC Form 4 · No Market Transaction
Stock Award
Compensation grant — no market purchase or sale.
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Gregory Russotti CIK 0001867305 |
CTO
|
Gregory Russotti at Century Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$40,140
More from this insider at Century Therapeutics Inc
| 2026-09-15 | Sell | -$4,993 | View |
| 2026-09-09 | Sell | -$1,095 | View |
| 2026-06-15 | Sell | -$5,767 | View |
| 2026-06-09 | Sell | -$1,106 | View |
| 2026-03-16 | Sell | -$25,684 | View |
Derivative Securities Transactions
| Title | Strike | Date | Type | Shares | Price | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.64 | 2023-02-02 | A - Award/Grant | 175,000 A | $0.00 | 2033-02-02 | 175,000 Common Stock | Direct |
| Stock Option (right to buy)F1 | $4.64 | 2023-02-02 | A - Award/Grant | 175,000 A | $0.00 | 2033-02-02 | 175,000 Common Stock | Direct |
Footnotes (1)
- F1
- The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. Show more
Related filings at Century Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
100
institutional managers reporting a position
Largest by reported value
- Ra Capital Management, L.P. $43.5M
- Tcg Crossover Management, Llc $43.4M
- Versant Venture Management, Llc $29.8M
5%+ Holders · 13D/G
6 filers
Other insiders at Century Therapeutics Inc
GET /v1/forms/4/0001062993-23-002310
API docs
View Original SEC Filing